The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 06.01.2025
Lilium
NL0015000F41
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lilium N.V. (“Lilium” or “the Company”) (NASDAQ: LILM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors w...
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Lilium N.V. (NASDAQ: LILM) (OTC: LILMF) between June 11, 2024 and November 3, 2024. Lilium describes itself as a “start-up aviation company-powered learning automation software company.”
For mo...
Law Offices of Howard G. Smith reminds investors of the upcoming January 6, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM, LILMW; OTC: LILMF) securities between June 11, 2024 and November 3, 2024, inclusive (the “Class Period”).
Investors...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lilium N.V. (“Lilium” or “the Company”) (NASDAQ: LILM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors w...
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM) and reminds investors of the January 6, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruq...
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 6, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM, LILMW; OTC: LILMF) securities between June 11, 2024 and November 3, 2024, incl...
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Lilium N.V. (NASDAQ: LILM) between June 11, 2024 and November 3, 2024. Lilium describes itself as a “start-up aviation company-powered learning automation software company.”
For more information, submit...
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM, LILMW; OTC: LILMF) securities between June 11, 2024 and November 3, 2024, inclusive (the “Class Period”). Lilium investors have until January 6, 2025 to file a lead plaintif...
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Kloster v. Lilium N.V., et al., Case No. 1:24-cv-08479, on behalf of persons and entities that purchased or otherwise acquired Lilium N.V. (“Lilium” or the “Company”) (NASD...
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM, LILMW) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Lilium inve...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .